Anti-CD20 antibodies to treat lymphoproliferative syndromes following renal transplantation.
Abderrahim
E
E
Department of Nephrology and Internal Medicine, Charles Nicolle Hospital, Tunis, Tunisia. abderrahim.ezzaddine@rns.tn
Karoui
C
C
Smaoui
W
W
Raies
L
L
Ben Abdallah
T
T
Hedri
H
H
Ben Moussa
F
F
Bardi
R
R
Ayed
K
K
Maïz
H Ben
HB
D000328:Adult; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015703:Antigens, CD / Q000276:immunology; D018951:Antigens, CD20 / Q000276:immunology*; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D016393:Lymphoma, B-Cell / Q000628:therapy*; D008232:Lymphoproliferative Disorders / Q000209:etiology* / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy; D013125:Spinal Neoplasms / Q000628:therapy; D016896:Treatment Outcome
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D018951:Antigens, CD20